Cynosure Advisors’s Biogen BIIB Stock Holding History

Cynosure Advisors’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-1,349	Closed	-$392K	–	37
2018 Q2	$392K	Hold	1,349	–	–	0.11%	147
2018 Q1	$369K	Buy	1,349 +13	+1%	+$4.04K	0.09%	149
2017 Q4	$426K	Buy	+1,336	New	+$429K	0.1%	132

Other funds holding BIIB

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Cynosure Advisors's BIIB Position: Q3 2018 in Review

Cynosure Advisors sold out of Biogen (BIIB) in Q3 2018, closing a stake of 1,349 shares — an estimated $392K sold.

Cynosure Advisors first reported a position in BIIB in Q4 2017 and held it in 3 quarters. The position peaked at $426K in Q4 2017. 1,145 funds tracked by Wall St. Rank hold BIIB as of Q3 2018.

Cynosure Advisors reported no remaining Biogen position as of Q3 2018 after selling out during the quarter.
Cynosure Advisors sold 1,349 Biogen shares in Q3 2018, an estimated $392K.
Cynosure Advisors first reported a position in Biogen in Q4 2017 and held it in 3 quarters.
Cynosure Advisors's Biogen position peaked at $426K in Q4 2017.
1,145 funds tracked by Wall St. Rank held Biogen as of Q3 2018.

Based on Cynosure Advisors's 13F filing for Q3 2018, filed 14 Nov 2018.